The antitumour activity of the prodrug N-l-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenografts

By Breistol K.   Hendriks H.R.   Berger D.P.   Langdon S.P.   Fiebig H.H.   Fodstad O.  

European Journal of Cancer, Vol. 34, Iss. 10, 1998-09 ,pp. : 1602-1606

Elsevier

Access to resources Recommend Favorite

Hyperthermia improves therapeutic efficacy of doxorubicin carried by mesoporous silica nanocontainers in human lung cancer cells

By Lee Hyemi   Kim Saehee   Choi Bo-Hwa   Park Moon-Taek   Lee Jeonghun   Jeong Seong-Yun   Choi Eun Kyung   Lim Byung-Uk   Kim Chulhee   Park Heon Joo  

International Journal of Hyperthermia, Vol. 27, Iss. 7, 2011-11 ,pp. : 698-707

Informa Healthcare

Access to resources Recommend Favorite

Determination of clinically therapeutic endoxifen concentrations based on efficacy from human MCF7 breast cancer xenografts

By Gong Inna  

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 61-69

Springer Publishing Company

Access to resources Recommend Favorite

Magnetic Resonance Imaging of Human Melanoma Xenografts in Vivo: Proton Spin-lattice and Spin-spin Relaxation Times Versus Fractional Tumour Water Content and Fraction of Necrotic Tumour Tissue

By Rofstad E.K.   Steinsland E.   Kaalhus O.   Chang Y.B.   Høvik B.   Lyng H.  

International Journal of Radiation Biology, Vol. 65, Iss. 3, 1994-03 ,pp. : 387-401

Informa Healthcare

Access to resources Recommend Favorite

Superior in vivo experimental antitumour activity of vinflunine, relative to vinorelbine, in a panel of human tumour xenografts

By Hill B.T.   Fiebig H.-H.   Waud W.R.   Poupon M.-F.   Colpaert F.   Kruczynski A.  

European Journal of Cancer, Vol. 35, Iss. 3, 1999-03 ,pp. : 512-520

Elsevier

Access to resources Recommend Favorite